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Objectives: To evaluate whether evascularisation has any influence on the mortality rate, and the impact of old age in 
patients with critical limb ischaemia (CLI). 
Design: Analysis of Swedish Vascular Registry (Swedvasc) data. 
Patients and methods: During 1987-1995, 3730 surgical and 1199 endovascular (PTA) procedures below the groin 
due to CLI were reported. At 1 year three groups were defined: "occluded, amputated"; 'occluded, not amputated" and 
"'patent". Survival was also calculated. Clinical outcome at 1 month and at 1 year was defined as: patient "'alive, 
improved", "alive, not improved", "alive, amputated" and "dead". Two age groups: <_ 75 years or and >_ 76 years were 
compared. 
Results: The mortality rate for the whole group was 5.3% at i month and 22.9% at 1 year, with no difference between 
the Surgery and PTA groups. Significantly more patients were alive and improved after surgery than after PTA at 
1 month (82.3% vs. 77.7%) and at 1 year (49.6% vs. 44.3%). The amputation rate was 5.6% at 1 month and 14.4% at 
1 year; 17% for diabetics. After surgery, the cumulative mortality rate did not differ between patients with a salvaged 
limb, irrespectively of patency of the re-construction, but was significantly higher after amputation. After PTA, only a 
reconstruction reported as patent was linked to the most favourable survival rate. The older patient group had a mortality 
rate of 6.4% at I month and 26.4% at 1 year, significantly higher than the younger group (3.8% and 17.6%, respectively). 
The amputation rate did not differ according to age. Significantly more patients were alive but not improved in the older 
group. 
Conclusions: The outcome of surgery vs. PTA was similar regarding survival and amputation, but surgery resulted in 
a greater improvement although this might be due to selection. Older patients and those with an amputation had higher 
mortality rates. 
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Introduction 
The prognosis for the patient suffering from CLI is far 
from satisfying. Studies point to a yearly mortality 
rate of 20%. 1 The Joint Vascular Research Group of the 
U.K. found that 60% of the patients were suitable for 
a revascularisation, while a further 20% needed an 
amputationF These figures seem to be very stable, 
although newer treatment options may save some of 
the legs which previously were amputated. On the 
other hand, a considerable number of limbs which are 
not salvaged by a reconstructive procedure may as 
the next step require an amputation. Important ques- 
tions are whether survival rates are influenced by 
revascularisation a d whether old age is associated 
* Please address all correspondence to: Z. Zdanowski, Department 
of Surgery, Lund University, S-221 85 Lund, Sweden. 
with inferior esults. This paper, based on the Swedish 
Vascular Registry (Swedvasc) 2 aims at analysing the 
role of age and survival after revascularisation in 
patients with critical imb ischaemia. 
Materials and Methods 
The Swedish Vascular Registry has existed since 1987. 
At the start it comprised about 20% of the Swedish 
population and from 1994 covered all of Sweden. 
Vascular procedures, including both surgery and en- 
dovascular interventions, are reported to the registry 
at the time of treatment at a 30-day follow-up and at 
an 1-year follow-up. The registry is also connected to 
the Swedish Population Registry, which means that 
mortality rates may be calculated beyond the 1-year 
follow-up. 
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Fig. 1. The two parts ofthe analysis: long-term survival according 
to the state of the reconstruction at 1 year and the difference in 
clinical outcome at one year in the two age groups below 76 and 
equal or above 76 years of age. 
Patients with critical limb ischaemia are reported 
with codes for rest pain, ulcers or gangrene, re- 
spectively (Fontaine grade III and IV). 3 Initially ankle 
pressures were reported asan ankle-brachial pressure 
index only, which means that these data were not 
easily comparable with the European definition which 
requires the absolute values of pressure levels. 4Further 
details from the registry have been presented else- 
where. 5
An analysis of 4929 patients treated with infra- 
inguinal revascularisation due to CLI between 1987- 
1995 was done. A surgical reconstruction was 
performed in 3730 cases, 1139 above the knee and 
2591 below the knee, and a percutaneous transluminal 
angioplasty (PTA) was done in 1199 cases, 891 above 
the knee and 308 below the knee. All procedures were 
performed either for rest pain (surgery n = 1666, PTA 
n =513), ischaemic ulcers (surgery n = 1359, PTA n = 
503) or gangrene (surgery n = 705, PTA n = 183). 
The influence of revascularisation  survival was 
investigated as follows: patients were categorised ac- 
cording to whether occlusion or amputation had been 
reported during the first year after surgery or PTA. 
Thus three groups were defined: "occluded, am- 
putated"; "occluded, not amputated" and "patent" 
(Fig. 1). Survival was thereafter calculated utilising 
data from the Swedish Population Register. 
Clinical outcome at 1 month and at 1 year was 
defined as: "alive, improved", "alive, not improved", 
"alive, amputated" and "dead" (Fig. 1). Furthermore, 
patients were divided into two age groups, 75 years 
or younger and 76 years or older. 
Survival was calculated according to the Cox pro- 
portional hazards method controlled for the presence 
of diabetes, sex and clinical stage. Age and presence 
of heart disease or hypertension were not included in 
the model as these variables did not differ significantly 
between categories. The confidence interval for the 
relative risk was calculated regarding mortality. The 
results were evaluated using the Chi-squared test for 
comparisons between groups. A p value <0.05 was 
regarded as significant. 
Results 
The mean age of the patients was 75.6 years with no 
difference between those treated with surgery and 
those undergoing PTA. There were 47% men and 53% 
women, 40% had diabetes and 55% cardiac disease. 
The 1 month and 1 year mortality rates were 5.3 and 
23%, respectively, without differences between the 
surgical and the PTA groups at I month and at I year. 
Significantly more patients were alive and improved 
after surgery than after PTA at 1 month (82.3% vs. 
77.7%) and at 1 year (49.6% vs. 44.3%) (p<0.0001). The 
proportion of patients alive but not improved at 1 
month were 7.5% after surgery and 12.3% after PTA, 
increasing to 17.4% and 23.0%, respectively, at 1 year 
(Table 1). 
Slightly fewer diabetic patients were alive and im- 
proved (73% compared to 76%) and they also had 
higher amputation rates (17% vs. 12.4%) than non- 
diabetics. The amputation rates were 5.6% at I month 
and 14.4% at 1 year for all patients. Patients with a 
gangrene, as the reported indication for surgery or 
PTA, had significantly more amputations than those 
with rest pain and ischaemic ulcers both at 1 month 
and at 1 year (10.8% vs. 4.4% and 24.9% vs. 12.1%, 
respectively, p<0.0001). There was no difference in 
1-year mortality rates for patients with procedures 
performed above the knee (23.4% for surgery and 
22.3% for PTA) compared to below the knee (24.7 and 
22.7%, respectively). 
Figures 2 and 3 show the cumulative survival for 
the three groups defined by the state of the re- 
construction at I year. After bypass urgery the relative 
risk for mortality was significantly less for the "pat- 
ent"-category (CI for RR 0.82~).95) and the non-am- 
putated (CI for RR 0.79-0.98) as compared to those 
amputated. After PTA only the "patent'-category had 
a mortality that significantly differed (CI for RR 0.64- 
0.82) from that of those amputated. The mean age of 
the patients younger than 76 years was 67.7 and of 
the older group (76 years and older) 81.7 years. When 
comparing patients in those two age groups a higher 
mortality rate was found in the older group at i month 
and at I year after surgery as well as after PTA. Tables 
2 and 3 display the results of the various procedures. 
No differences were recorded in amputation rates for 
the two groups at 1 month and 1 year. On the other 
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Table 1. 30 days and one year outcome in 3730 patients treated with surgery and 
1199 patients treated with PTA. 
30 days 1 year 
Surgery PTA Surgery PTA 
% % % % 
Alive, improved 82.3 77.7 49.6 44.3 
Alive, not improved 7.5 12.3 17.4 23.0 
Alive, amputated 4.8 5.0 10.1 9.8 
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Fig. 2. The cumulative survival of three patient groups (n =3730), 
treated with bypass for CLI, defined by the state of the reconstruction 
at 1 year. The relative risk for mortality was significantly less for 
the "patent"-category and the non-amputated as compared to those 
amputated. State at 1 year: ( - -)  occl/amp; (---) occl/non-amp; 
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Fig. 3. The cumulative survival of three patient groups (n = 1199), 
treated with PTA for CLI, defined by the state of the reconstruction at 
1 year. Only the "patent"-category had a mortality that significantly 
differed from that of those amputated. Key as for Fig. 2. 
hand, the older group had a significantly lower rate 
of patients "alive and improved" than the younger 
group at 1 month and at 1 year. (Surgery p<0,05 and 
p<0.0001, PTA p<0.05 and p<0.05, respectively). 
Discuss ion  
Most reports on the results of revascularisation for 
critical l imb ischaemia have been from single 
centres. 6'7 Myers et al. presented 750 femorodistal pro- 
cedures, finding that diabetes was an independent 
prognostic ovariate, while the patients' age was not. 7 
Less frequently, data are compiled from groups of 
centres, one example being The Joint Vascular Research 
Group in the U.K., 1 from which it was learnt that there 
was a 20% yearly mortality in patients uffering from 
CLI, a figure which still holds true. The present report 
compiled data from Swedvasc, which includes vas- 
cular centres from both county hospitals and university 
hospitals. 
Long-term survival is infrequently reported. How-  
ever, it is known that 5 years after a major amputation, 
the mortality rate is between 50-100%. 8 In a recent 
study from The Netherlands, Hoofwijk reported the 
long-term outcome of 289 patients with Fontaine stages 
III and IV, which compares well with the present 
material. 9 The 1-year mortality rate was 27.4%. The 
author used a score to describe the patients' condition 
preoperatively. This score, but not the age of the 
patients, or any other parameter, predicted the 
patients' survival. Our results in terms of the 1-year 
mortality compare favourably to this single centre 
report, and most probably this is also true for the long- 
term mortality (Swedvasc 50-60% at 6 years, The 
Netherlands tudy 41% at 3.5 years). 
Patency and limb salvage are evidently not always 
the same. Patent reconstructions without limb salvage 
are reported, as well as limb salvage with occluded 
grafts. In a detailed analysis of the I loprost Bypass 
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Table 2. 30 days outcome in 2973 patients 76 years of age or older and 1956 
patients 75 years or younger treated with either surgery (<76 years no. = 1535; -> 76 
years n=2195) or PTA (<76 years no.=421; _>76 years n=778). The difference in 
outcome between age groups was significant (surgery p<0.05; PTA p<0.05). 
Surgery PTA 
<76 _> 76 <76 > 76 
% % % % 
Alive, improved 82.3 81.2 81.5 75.7 
Alive, not improved 7.0 7.8 10.0 13.5 
Amputated 5.2 4.5 5.5 4.8 
Dead 4.0 6.5 3.1 6.0 
Table 3. One year outcome in patients presented in Table 2. The difference in 
outcome between age groups was significant (surgery p<0.0001; PTA p<0.01). 
Surgery PTA 
<76 _>76 <76 >76 
% % % % 
Alive, improved 55.0 45.8 48.5 42.0 
Alive, not improved 17.4 17.4 24.7 22.1 
Amputated 9.9 10.2 9.3 10.0 
Dead 17.6 26.6 17.6 25.8 
Study 1° it was shown that 17% of patients with a 
patent bypass remained critically ischaemic, while 13% 
improved despite an occluded bypassJ a Swedvasc 
parameters ecording improvement do not necessarily 
imply a patent reconstruction. Although the variable 
"patency" is reported, it is not always based on ob- 
jective evidence, such as ABPI or imaging. "Patency" 
is a difficult parameter to establish, especially after 
PTA. This study showed that neither the 1-year mor- 
tality rate nor the cumulative mortality rate differed 
significantly between open and occluded re- 
constructions as long as the limb was saved, albeit 
with a slight difference between the two treatment 
groups. There may be various explanations, the most 
probable one is that the critical ischaemia had been 
relieved while the reconstruction stayed open, and 
further deterioration did not appear. Revascularisation 
apparently reduces mortality compared to amputation. 
However, the results once again stress that amputation 
is the main predictor of mortality. The finding that 
diabetic patients had a higher amputation rate was 
expected. The worse outcome for diabetic patients, as 
well as for female patients has been verified in other 
studies, including a recent Finnish review on distal 
reconstruction. 12 The amputation rate was higher in 
patients with gangrene, compared to those suffering 
an ischaemic ulcer or rest pain only. Differences in 
outcome for these various stages of CLI are usually 
recorded, and it may be reasonable to describe the 
results of a reconstruction and the true outcome sep- 
arately for these groups. 13 
From several reports n'14'15 it seems evident that 
old age should not exclude a patient with CLI from 
a reconstruction. On the other hand, the older group 
consumes more hospital costs and has a higher 
mortality rate. 16 The age limits vary, but 75 years 
seems a relevant break point. The results of the 
reconstructions at 1 month are in line with most 
reports. The older age group had a significantly 
higher mortality after surgery. On the other hand, 
the figures of 6.5% and 4.0%, respectively, were 
both within an acceptable range. The reason that 
corresponding figures after PTA (6.0% vs. 3.1%) did 
not differ statistically might be the smaller sample. 
A dramatic decrease of the group "alive and im- 
proved" was recorded at 1 year and mortality was 
significantly higher in the older age group. The total 
mortality rate at 1 year (23%) is comparable with 
previous figures and there was little difference 
between those patients treated by PTA and those 
undergoing a surgical reconstruction. 
In conclusion, based on the Swedvasc results and 
when contraindications donot exist, an attempt should 
be made to save a critically ischaemic leg by balloon 
angioplasty or surgical reconstruction. This decision 
should not be based on age alone, accepting that there 
will be a higher long-term mortality in older patients. 
In studies to come, quality of life factors should also 
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be assessed.  The  funct iona l  outcome and  qua l i ty  of 
l i fe might  be  of much  greater  impor tance  to the  pat ient  
than  the  techn ica l  result .  I~'I7-19 
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